Protective effect of cold autologous blood cardioplegic solution on the heart of infants with cyanotic congenital heart disease

MA Chao, SHEN Ding-Rong, ZHANG Qing, MENG Xiang-Chun, WANG Yuan-Xiang, PENG Le, MENG Bao-Ying

Chinese Journal of Contemporary Pediatrics ›› 2013, Vol. 15 ›› Issue (6) : 453-457.

PDF(1032 KB)
PDF(1032 KB)
Chinese Journal of Contemporary Pediatrics ›› 2013, Vol. 15 ›› Issue (6) : 453-457. DOI: 10.7499/j.issn.1008-8830.2013.06.014
CLINICAL RESEARCH

Protective effect of cold autologous blood cardioplegic solution on the heart of infants with cyanotic congenital heart disease

  • MA Chao, SHEN Ding-Rong, ZHANG Qing, MENG Xiang-Chun, WANG Yuan-Xiang, PENG Le, MENG Bao-Ying
Author information +
History +

Abstract

OBJECTIVE: To study the protective effect of cold autologous blood cardioplegic solution on the heart of infants with cyanotic congenital heart disease (CCHD). METHODS: Ninety-six infants with CCHD who underwent cardiopulmonary bypass (CPB) were randomly and equally divided into three groups: histidine-tryptophan-ketoglutarate (HTK) solution, cold non-autologous blood cardioplegic solution, and cold autologous blood cardioplegic solution. The right auricular tissues were taken before aortic cross-clamping and at 30 minutes after aortic declamping, and ATP level and energy charge (EC) in the myocardium were measured. Venous blood was collected before and immediately after CPB, and the serum levels of creatine kinase (CK)-MB and cardiac troponin I (cTnI) were measured. The clinical parameters, such as the re-beat time and re-beat rate during CPB, cardiac index, dependence on positive inotropic agents, and left ventricular ejection fraction (LVEF) at 2 hours after CPB, the incidence rate of arrhythmia within 24 hours after CPB, and postoperative complications and mortality, were recorded. RESULTS: At 30 minutes after aortic declamping, the three groups showed significantly decreased ATP and EC levels (P<0.05), and the cold autologous blood group had significantly higher ATP and EC levels than the other two groups (P<0.05). Immediately after CPB, the three groups showed significantly increased serum levels of CK-MB and cTnI (P<0.05), and the cold autologous blood group had significantly lower serum levels of CK-MB and cTnI than the other two groups (P<0.05). The cold autologous blood group had significantly better outcomes than the other two groups in terms of the re-beat time during CPB and the dependence on positive inotropic agents and LVEF at 2 hours after CPB (P<0.05). CONCLUSIONS: Cold autologous blood cardioplegic solution is superior to HTK and cold non-autologous blood cardioplegic solutions in preserving myocardial energy and reducing myocardial injury in infants with CCHD who undergo CPB, thus providing a better protective effect on the heart.

Key words

Immature myocardium / Cyanotic congenital heart disease / Cold autologous blood cardioplegic solution / Myocardial injury / Infant

Cite this article

Download Citations
MA Chao, SHEN Ding-Rong, ZHANG Qing, MENG Xiang-Chun, WANG Yuan-Xiang, PENG Le, MENG Bao-Ying. Protective effect of cold autologous blood cardioplegic solution on the heart of infants with cyanotic congenital heart disease[J]. Chinese Journal of Contemporary Pediatrics. 2013, 15(6): 453-457 https://doi.org/10.7499/j.issn.1008-8830.2013.06.014

References

[1]Kaczorowski DJ, Tsung A, Billiar TR. Innate immune mechanisms in ischemia/reperfusion[J]. Front Biosci, 2009, 1: 91-98.

[2]Peart JN, Headrick JP. Clinical cardioprotection and the value of conditioning responses[J]. Am J Physiol Heart Circ Physiol, 2009, 296(6): H1705-H1720.

[3]杨娜, 刘邕波, 刘陶文. 未成熟心肌保护的研究进展[J]. 医学综述, 2010, 16(8): 1205-1207.

[4]徐树彬. 未成熟心肌再氧合损伤的研究进展[J]. 医学综述, 2009, 15(6): 864-866.

[5]Ihnken K. Myocardial protection in hypoxic immature hearts[J]. Thorac Cardiovasc Surg, 2000, 48(1): 46-54.

[6]王华, 李欣, 殷凤珍.  受损心脏体外循环过程中复苏困难的处理[J]. 中国体外循环杂, 2004, 2(1): 49-50.

[7]Durandy Y. Pediatric myocardial protection[J]. Curr Opin Cardiol, 2008, 23(2): 85-90.

[8]刘超, 闵苏. 心肌保护液添加剂的研究进展[J]. 临床麻醉学杂志, 2011, 27(1): 87-89.

[9]王鹏高, 罗淑颖, 牛松涛, 张卫东. 不同心脏停搏液对体外循环中未成熟心肌保护作用的研究[J]. 中国现代医生, 2009, 47(12): 20-22.

[10]于坤, 刘迎龙. 冷血停搏液对法洛四联症婴幼儿心肌代谢的影响[J]. 中华胸心血管外科杂志, 2002, 18(2): 96-98.

[11]沈定荣, 王涛, 张青, 马超, 孟保英. 自体冷血心脏停搏液对未成熟心肌细胞三磷酸腺苷及二磷酸腺苷的影响[J]. 中国体外循环杂, 2010, 8(4): 215-218.

[12]张青, 孟保英, 彭乐, 王涛, 马超, 陶静. 自体冷血停跳液对婴幼儿心肌保护机制的研究[J]. 中国当代儿科杂志, 2009, 11(8): 638-640.

[13]刘哲亮, 吴忠仕, 胡建国, 杨一峰, 陈勇, 高华, 等. 紫绀型先天性心脏病患儿血清VEGF和SDF1水平与循环EPCs的相关性研究[J]. 中国当代儿科杂志, 2009, 11(4): 267-272.

[14]Wang M, Wang Y, Abarbanell A, Tan J, Weil B, Herrmann J, et al. Both endogenous and exogenous testosterone decrease myocardial STAT3 activation and SOCS3 expressionafter acute ischemia and reperfusion[J]. Surgery, 2009, 146: 138-144.

[15]蹇朝, 马瑞彦, 王咏, 陈劲进, 陈林, 钟前进,  等. 缺氧诱导因子-1α在紫绀型先心病患儿心肌中的表达[J]. 第三军医大学学报, 2009, 31(12): 1189-1192.

[16]张青, 王涛, 彭乐, 马超, 孟保英, 赵春玉. 自体冷血停搏液对婴幼儿心肌保护作用[J]. 中国体外循环杂志, 2009, 7(1): 1-3.

PDF(1032 KB)

Accesses

Citation

Detail

Sections
Recommended

/